Medisafe Improves Adherence and Lowers Costs For Chronic Disease Patients
Medisafe collaborated with IMS Health to conduct a study evaluating med adherence among Medisafe users with hypertension, hyperlipidemia and diabetes against a control group.Read more.
The Impact of Medisafe’s ‘Medfriend’ caregiver feature on Adherence
Medisafe analyzed 1,617 non-adherent active users two weeks before and two weeks after they added a Medfriend. 71% of users improved medication adherence after adding a Medfriend.Read more.
Medisafe Significantly Lowers Users’ Blood Pressure
Medisafe app users experienced significant improvements in their blood pressure levels over a 30-day period, with stage 2 hypertensives decreasing their systolic blood pressure by 25.3 mmHg.Read more.